TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
Author:
Affiliation:
1. Centre de Recherche en Cancérologie de Lyon, Lyon, France.
2. ErVaccine Technologies, Lyon, France.
3. Centre Léon Bérard, Lyon, France.
4. Université Claude Bernard Lyon 1, Lyon, France.
Abstract
Publisher
American Association for the Advancement of Science (AAAS)
Subject
Multidisciplinary
Link
https://www.science.org/doi/pdf/10.1126/sciadv.adf3700
Reference121 articles.
1. The Wild West of Checkpoint Inhibitor Development
2. Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy
3. A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
4. TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
5. CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings;Biochemistry and Cell Biology;2024-02-01
2. A general platform for targeting MHC-II antigens via a single loop;2024-01-30
3. “Digital twins elucidate critical role of Tscm in clinical persistence of TCR-engineered cell therapy”;npj Systems Biology and Applications;2024-01-26
4. In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials;Advanced Materials;2024-01-22
5. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs;Experimental Hematology & Oncology;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3